A pilot study conducted at the University of Maryland Lyme Program evaluated the feasibility and impact of a multimodal integrative therapeutic intervention for patients with chronic symptoms attributed to a postinfectious syndrome. Participants attended two 1-hour individual instructional sessions, consisting of Ayurveda-based dietary intervention and breath-coordinated mind-body practice. Results showed that the intervention improved physical and mental health, fatigue, anxiety, and pain over a 12-month period. Employment status had significant effects on almost all outcome scores, and postinfectious state was associated with improvement in anxiety and PSS scores. The study concludes that a multimodal Ayurvedic and breath-coordinated mind-body therapeutic intervention is feasible and a potential nonpharmacologic therapeutic option for postinfectious syndrome patients.A Multimodal Ayurveda and Mind-Body Therapeutic Intervention for Chronic Symptoms Attributed to a Postinfectious Syndrome: A Pilot Study - PubMed (nih.gov)
***********
This review aims to educate healthcare professionals and the public about Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), a complex, chronic medical condition characterized by symptoms such as fatigue, malaise, cognitive dysfunction, immune dysfunction, sleep issues, pain, autonomic dysfunction, neuroendocrine and immune symptoms. ME/CFS is common, often disabling, and costly, with the Institute of Medicine (IOM) estimating between 836,000 and 2.5 million Americans affected annually. The disease is often misdiagnosed and treated, leading to patients suffering from unmet healthcare needs and food insecurity. The exact etiology of ME/CFS is unknown, but recent research is beginning to shed light on its causes, including infectious, genetic, immune, cognitive, metabolic, and biochemical abnormalities. Management involves supportive symptomatic treatment and strategic rest periods. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians - PubMed (nih.gov)
************
The study compared flow-mediated dilation values between Long COVID, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), and healthy age-matched controls. Results showed significantly impaired endothelial function in both groups compared to healthy controls. Despite longer illness duration in ME/CFS, there was no difference in flow-mediated dilation between the two groups. The study suggests an increased cardiovascular risk in these populations, requiring careful monitoring and targeted interventions to improve endothelial function and mitigate long-term health implications. People With Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Exhibit Similarly Impaired Vascular Function - PubMed (nih.gov)
************
The COVID-19 pandemic, caused by SARS-CoV-2, primarily causes acute respiratory infections but can lead to neurological complications and long-term sequela. Common symptoms include fatigue, myalgias, depression, anxiety, and cognitive and memory impairments. Even mild infections can cause neuroinflammation, impairing hippocampal neurogenesis and depleting oligodendrocytes. Strategies to restrain neuroinflammation, maintain better hippocampal neurogenesis, and preserve oligodendrocyte lineage differentiation may reduce the incidence of long-COVID. Role of Microglia, Decreased Neurogenesis and Oligodendrocyte Depletion in Long COVID-Mediated Brain Impairments - PubMed (nih.gov)
***************
This study aims to demonstrate that oxygen consumption is a biomarker for Myalgic Encephalomyelitis (ME/CFS), a severe chronic disease. The researchers used two datasets: SF-36 responses from 2,347 confirmed records and a validation set of 239 cardiopulmonary exercise test results. The results showed a direct link between the Weber classification and the SF-36 questionnaire score. The 36-response matrix in the machine learning model was found to be more reliable than the subscale matrix for classifying patients with ME/CFS. The study suggests that low oxygen consumption on CPET can be considered a biomarker in ME/CFS patients. Unsupervised cluster analysis reveals distinct subtypes of ME/CFS patients based on peak oxygen consumption and SF-36 scores - PubMed (nih.gov)

Comments
Post a Comment